NextCure, Inc.
New Filing
CIK: 0001661059·Biotechnology·DELAWARE·Filed: Nov 19, 2018
Total Offering
$93,432,873
Amount Sold
$93,432,873
Investors
22
First Sale
Nov 5, 2018
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired, Other: Series B Preferred and Common Stock issuable upon the conversion thereof
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2015
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Michael Richman | Related Person |
| David Kabakoff | Related Person |
| Judith Li | Related Person |
| Stella Xu | Related Person |
| Michael Yi | Related Person |
| Steven Cobourn | Related Person |
| Kevin N. Heller | Related Person |
| Elaine V. Jones | Related Person |
| Chau Q. Khuong | Related Person |
| Tim Shannon | Related Person |
Company
SEC Filing
0001567619-18-006604
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free